High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial

• L. John Hoffer ,

  * E-mail: l.hoffer@mcgill.ca

  Affiliation Department of Medicine, Jewish General Hospital, Montreal, Canada

  ⨯
• Line Robitaille,

  Affiliation Lady Davis Institute for Medical Research, Montreal, Canada

  ⨯
• Robert Zakarian,

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Clinical Research Unit, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada

  ⨯
• David Melnychuk,

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Department of Oncology, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada

  ⨯
• Petr Kavan,

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Departments of Oncology and Medicine, Segal Cancer Centre, Montreal, Canada

  ⨯
• Jason Agulnik,

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Departments of Medicine and Oncology, Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Canada

  ⨯
• Victor Cohen,

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Departments of Oncology and Medicine, Segal Cancer Centre, Montreal, Canada, Departments of Medicine and Oncology, Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Canada

  ⨯
• David Small,

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Departments of Medicine and Oncology, Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Canada

  ⨯
• Wilson H. Miller Jr.

  Affiliations Lady Davis Institute for Medical Research, Montreal, Canada, Clinical Research Unit, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada, Departments of Oncology and Medicine, Segal Cancer Centre, Montreal, Canada

  ⨯